Xconomy National

Archives

by in

Entry	Author	Date	Location
Infinity Drug Fails in Pancreatic Cancer Trial, Shares Fall	Luke Timmerman	01/27/12	Boston
Aveo (Barely) Passes Study With Kidney Cancer Drug, Stock Falls	Luke Timmerman	01/03/12	Boston
Aastrom Reports Positive Phase 2 Trial Results	Sarah Schmid	11/15/11	Detroit
AMAG Stock Rises, Ariad Drug Shows Improved Safety, Rhythm Adds Merck Veteran as CEO, & More Boston-Area Life Sciences News	Erin Kutz	11/11/11	Boston
Theraclone Enters Clinical World, With Flu Antibody That Might Be Handy in Pandemic	Luke Timmerman	09/21/11	Seattle
Mascoma Seeks IPO, Tokai Takes in $23M, Boston-Power Gets $125 for Shift to China, & More Boston-Area Deals News	Erin Kutz	09/21/11	Boston
Zogenix Pain Drug Meets Endpoint	Bruce V. Bigelow	08/17/11	San Diego
AVI Starts Duchenne Trial	Luke Timmerman	08/15/11	Seattle
Meritage Pharma Passes Key Test With Drug to Reduce Swelling of the Food Pipe	Luke Timmerman	05/10/11	San Diego
Bluebird Bio Snaps up $30M for Gene Therapies, Adds ARCH Venture to Syndicate	Ryan McBride	04/20/11	Boston
Sangart Gets $50M Infusion for Oxygen-Carrying Blood Adjunct	Bruce V. Bigelow	04/19/11	San Diego
Gilead Drug Fails AIDS Prevention Trial	Luke Timmerman	04/18/11	San Francisco
Biotech’s Missed Opportunity: Small-Town and Rural America	Luke Timmerman	04/18/11	National
Public Policy Institute on How to Boost Biotech in New York: More Jobs, Better Teamwork, Fewer Taxes	Arlene Weintraub	04/12/11	New York
Biogen Idec Passes Pivotal Trial With Oral MS Drug; Shares Climb	Luke Timmerman	04/11/11	Boston
Omeros Flunks Pivotal Trials, Dendreon’s Shareholder Hubbub, AVI Biopharma Nabs $30M, & More Seattle-Area Life Sciences News	Luke Timmerman	04/07/11	Seattle
Tolerx and Glaxo Diabetes Drug Disappoints in Late-Stage Study	Ryan McBride	03/11/11	Boston
RXi Sells Stock and Warrants, Cardiorobotics Raises $6.6M, ImmunoGen Dishes On New Drugs, & More Boston-Area Life Sciences News	Erin Kutz	03/04/11	Boston
Quanterix Partners With Novartis, Athenahealth and Microsoft Sync Up, Vertex Nails Clinical Trial, & More Boston-Area Life Sciences News	Erin Kutz	02/25/11	Boston
Vertex Nails Pivotal Study for Cystic Fibrosis, Racing Toward Market With Second Drug	Luke Timmerman	02/23/11	Boston
Jennerex, Maker of Cancer-Fighting Virus, Says Early Data Shows Survival Benefit	Luke Timmerman	02/17/11	San Francisco
Stromedix Chief, After Reloading the Company Treasury, Sets Sight on Trial for Deadly Lung Disease	Ryan McBride	02/07/11	Boston
Clinical Data Stock Surging on FDA Approval of Anti-Depression Drug	Ryan McBride	01/24/11	Boston
Plexxikon, Roche Drug Extends Lives in Patients With Deadly Skin Cancer	Luke Timmerman	01/19/11	San Francisco
Ariad Pharma Stock Up More than 25 Percent on Positive Phase III Data	Ryan McBride	01/18/11	Boston
Allon Starts Trial for Brain Disease	Luke Timmerman	01/06/11	Seattle
Syndax Pharma Study Offers Clues that Lung Cancer Treatment Could Benefit Subset of Patients	Ryan McBride	12/10/10	Boston
Seattle Genetics, Millennium’s Encore: Souped-Up Antibody Looks Better in 2nd Trial	Luke Timmerman	12/07/10	Seattle
Glaxo Ends Resveratrol Drug Study	Ryan McBride	12/01/10	Boston
Pearl Therapeutics, Fresh Off Big VC Round, Tops $3B Lung Drug in Head-to-Head Trial	Luke Timmerman	12/01/10	San Francisco
Page 1 of 8	next page »